Article
Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches
11 Jun 2021
Abstract excerpt
Cervical cancer, caused by human papillomavirus (HPV), is the fourth most common type of cancer among women worldwide. While HPV prophylactic vaccines are available, they have no therapeutic effects and do not clear up existing infections. This study aims to design a therapeutic vaccine against cervical cancer using reverse vaccinology. In this study, the E6 and E7 oncoproteins from HPV16 were chosen as the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
